Stratification for F-L Therapy After LT

Completed

• Conditions: Liver Transplantation; Adjuvant FOLFOX Plus Lenvatinib; Machine Learning

• Registration Number: NCT06564103
• Lead Sponsor: Xiao Xu

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-8-19
• Last Update Posted: 2 September 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 1

Inclusion Criteria

Inclusion Criteria:<br><br> - patients fulfilling the Hangzhou criteria or exceeding the Hangzhou criteria with<br> type 1 or 2 portal vein tumor thrombus (PVTT) before LT<br><br>Exclusion Criteria:<br><br> - <br><br> 1) individuals less than 18 years old; 2) individuals with malignancies other than<br> HCC; 3) individuals who survived less than 30 days after LT; and 4) individuals<br> who lacked important prognostic variables, such as contrast-enhanced CT imaging<br> information one month before transplantation, preoperative alpha-fetoprotein<br> (AFP) levels, and tumor differentiation data

Exclusion Criteria

Not provided

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The disease-free survival rate was evaluated by follow-up investigation and outpatient review

Secondary Outcome Measures

Name	Time	Method
The overall survival rate was evaluated by follow-up investigation and outpatient review